As of 2025-03-24, the EV/EBITDA ratio of KemPharm Inc (KMPH) is -6.44. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KMPH's latest enterprise value is 153.95 mil USD. KMPH's TTM EBITDA according to its financial statements is -23.90 mil USD. Dividing these 2 quantities gives us the above KMPH EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 7.8x - 9.5x | 8.4x |
| Forward P/E multiples | 9.4x - 17.0x | 12.8x |
| Fair Price | (5.13) - (5.23) | (6.03) |
| Upside | -188.4% - -190.0% | -203.8% |
| Date | EV/EBITDA |